AirBoss Announces New Order Valued at up to US$8.1M for Canadian Department of National Defense

(TSX:BOS),(OTC US:ABSSF),(Other OTC:ABSSF), NEWMARKET, Ontario, Nov. 10, 2025 (GLOBE NEWSWIRE) — AirBoss of America Corp. (TSX: BOS) (OTCQX:ABSSF) (the “Company” or “AirBoss”) today announced that AirBoss Defense Group (“ADG”), AirBoss Manufactured Products' (“AMP”) defense business, has received an order from the Canadian Department of National Defense (“Canadian DND”) for ADG's Low Burden Masks (“LBM”), filters […]

Kamada Reports Strong Third Quarter and Nine Month 2025 Financial Results with over 30% Year-over-Year Profitability Growth

(TASE:KMDA.TA),(NASDAQ:KMDA), Third Quarter Revenues of $47.0 Million, up 13% Year-over-Year, and Adjusted EBITDA of $11.7 Million, up 34% Year-Over Year Nine Month Revenue of $135.8 Million, up 11% Year-over-Year; Adjusted EBITDA of $34.2 Million, up 35% Year-over-Year Positive Outlook for Remainder of 2025 Based on the Company's Diverse Product Portfolio Supports Full-Year Revenue Guidance of

Roivant Reports Financial Results for the Second Quarter Ended September 30, 2025, and Provides Business Update

Roivant Reports Financial Results for the Second Quarter Ended September 30, 2025, and Provides Business Update GlobeNewswire November 10, 2025 BASEL, Switzerland and LONDON and NEW YORK, Nov. 10, 2025 (GLOBE NEWSWIRE) — Roivant (Nasdaq: ROIV) today reported its financial results for the second quarter ended September 30, 2025, and provided a business update. Brepocitinib

TransPerfect Launches Operations in Saudi Arabia

RIYADH, Saudi Arabia and NEW YORK, Nov. 10, 2025 (GLOBE NEWSWIRE) — TransPerfect, the world's largest provider of language and AI solutions for global business, today announced the opening of a new office in Riyadh, Kingdom of Saudi Arabia (KSA). The Riyadh office is TransPerfect's first location in Saudi Arabia and reflects the company's continued

eToro Reports Third Quarter 2025 Results

eToro Reports Third Quarter 2025 Results GlobeNewswire November 10, 2025 Net Contribution grew by 28% year-over-year to $215 millionAssets Under Administration grew by 76% year-over-year to $20.8 billionFunded accounts grew by 16% year-over-year to 3.73 millionAnnounced a $150 million share repurchase program NEW YORK, Nov. 10, 2025 (GLOBE NEWSWIRE) — eToro Group Ltd. (“eToro”, or

Tenaya Therapeutics Reports Third Quarter 2025 Financial Results and Provides Business Update

Tenaya Therapeutics Reports Third Quarter 2025 Financial Results and Provides Business Update GlobeNewswire November 10, 2025 Presentation of MyPEAK-1 Data and the American Heart Association Scientific Sessions Showed Consistent, Deeper, and Durable Improvement in Measures of Hypertrophy for Cohort 1 Patients Initial TN-201 Cohort 2 Data Demonstrated Early Dose Responsive Increases in TN-201 Transduction and

Day One Announces New OJEMDA(TM) (tovorafenib) Data to be Presented in Oral Session at the 2025 Society for Neuro-Oncology (SNO) Annual Meeting

Day One Announces New OJEMDA(TM) (tovorafenib) Data to be Presented in Oral Session at the 2025 Society for Neuro-Oncology (SNO) Annual Meeting GlobeNewswire November 10, 2025 Three-year follow-up data from FIREFLY-1 demonstrates durable responses with evidence of clinical stability off treatment, with the potential for retreatment after progression Treatment-free interval data to also be disclosed

Norwegian Cruise Line Holdings Confirms Newbuild Order for Third Prestige-Class Ship for Regent Seven Seas Cruises

Norwegian Cruise Line Holdings Confirms Newbuild Order for Third Prestige-Class Ship for Regent Seven Seas Cruises GlobeNewswire November 10, 2025 MIAMI, Nov. 10, 2025 (GLOBE NEWSWIRE) — Norwegian Cruise Line Holdings Ltd. (NYSE: NCLH), a leading global cruise company operating Norwegian Cruise Line, Oceania Cruises, and Regent Seven Seas Cruises, today announced it has confirmed

HCW Biologics Shares the Latest Data for its Second-Generation Immune Checkpoint Inhibitor Presented at the 40th Annual Meeting of the Society for Immunotherapy of Cancer

HCW Biologics Shares the Latest Data for its Second-Generation Immune Checkpoint Inhibitor Presented at the 40th Annual Meeting of the Society for Immunotherapy of Cancer HCW11-040 is a first-in-class pembrolizumab-based, tetra-valent immune checkpoint inhibitor designated as Company's franchise immunotherapeutic for internal clinical development GlobeNewswire November 10, 2025 MIRAMAR, Fla., Nov. 10, 2025 (GLOBE NEWSWIRE) —

Pixalate’s October 2025 United Kingdom Publisher Rankings: Top Mobile ‘Sports’ Apps For Programmatic Advertising Traffic Quality in the Apple App Store and Google Play Store

Pixalate's October 2025 United Kingdom Publisher Rankings: Top Mobile 'Sports' Apps For Programmatic Advertising Traffic Quality in the Apple App Store and Google Play Store GlobeNewswire November 10, 2025 According to Pixalate's October 2025 rankings, 'OneFootball: All Soccer Scores' was No. 1 on Apple App Store, and 'LiveScore: Live Sports Scores' was top-ranked on Google

Scroll to Top